National Health and Medical Research Council

Home
Skip Navigation and go to Content
Explore NHMRC
 
Close sitemap

Strategic Review of Health and Medical Research in Australia

Welcome to the resource page developed by NHMRC to support the 2012 Strategic Review of Health and Medical Research in Australia (The Review).  We have collated key reference material relevant to The Review Terms of Reference including links to information on the NHMRC website and other important data sources to assist organisations and individuals.  This is not intended to be a comprehensive list. 

General information for The Review is provided on the official Review Panel website which identifies thirteen ‘Matters for Review’ and states:  “The review will take into account broader Government policy, including the Government’s fiscal strategy, and will focus on optimising Australia’s capacity to produce world class health and medical research to 2020, including reference to the following matters:…” 

NHMRC Submission to the Strategic Review of Health and Medical Research in Australia

Public Meeting Schedule for the Review

The Panel of the Strategic Review of Health and Medical Research in Australia (the Review) held its fifth private meeting on Wednesday 4 April 2012 in Canberra.

The Panel has now received over 300 submissions, many of which are from key stakeholders in health and medical research. The Panel called for written submissions in early February 2012, with submissions due by 30 March 2012.

Public consultations will commence in mid April 2012 and continue through until July. Consultations are planned for each capital city of Australia and both private meetings with major stakeholders and a public workshop with all other interested stakeholders, including members of the public, will be held in each city.
The Review's public meeting schedule is as follows:

  • Hobart : 18 April 2012 - Public meeting from 1.00 to 3.00 pm at The Old Woolstore Apartment Hotel, 1 Macquarie Street, Hobart
  • Canberra : 19 April 2012 - Public meeting from 2.00 to 4.00 pm at CSIRO Corporate Centre, Limestone Avenue, Campbell
  • Melbourne : 1 May 2012 - (afternoon) time & venue TBA
  • Darwin : 8 May 2012 - (afternoon) time & venue TBA
  • Brisbane : 29 May 2012 - (afternoon) time & venue TBA
  • Adelaide : 5 June 2012 - (afternoon) time & venue TBA
  • Perth : 6 June 2012 - (afternoon) time & venue TBA
  • Sydney : 5 July 2012 - (afternoon) time & venue TBA

Information about times and venues for each city after Canberra will be posted on the Review website here and confirmation emails sent to all people who have email addresses registered with the review.

The Panel urges all interested people and organisations to register their interest in attending the public meetings on the Review website.

The Panel is to provide a report to the Australian Government in late 2012 which will include recommendations for a 10-year, national, strategic health and medical research plan.

The Panel's next private meeting is planned for early May 2012 in Canberra.

The terms of reference for the review are provided here.  

The ‘Matters for Review’ are quoted below with related key reference material and a brief contextual description provided under 'view resources'.

The description of each item is provided by NHMRC, unless otherwise indicated.
 

  1. The need for Australia to build and retain internationally competitive capacity across the research spectrum, from basic discovery research through clinical translation to public health and health services research.

    View Resources

  2. Current expenditure on, and support for, health and medical research in Australia by governments at all levels, industry, non-government organisations and philanthropy; including relevant comparisons internationally.

    View Resources

  3. Opportunities to improve coordination and leverage additional national and international support for Australian health and medical research through private sector support and philanthropy, and opportunities for more efficient use, administration and monitoring of investments and the health and economic returns; including relevant comparisons internationally.

    View Resources

  4. The relationship between business and the research sector, including opportunities to improve Australia’s capacity to capitalise on its investment in health and medical research through commercialisation and strategies for realising returns on Commonwealth investments in health and medical research where gains result from commercialisation.

    View Resources

  5. Likely future developments in health and medical research, both in Australia and internationally.

    View Resources

  6. Strategies to attract, develop and retain a skilled research workforce which is capable of meeting future challenges and opportunities.

    View Resources

  7. Examine the institutional arrangements and governance of the health and medical research sector, including strategies to enhance community and consumer participation. This will include comparison of the NHMRC to relevant international jurisdictions.

    View Resources

  8. Opportunities to improve national and international collaboration between education, research, clinical and other public health related sectors to support the rapid translation of research outcomes into improved health policies and practices. This will include relevant international comparisons.

    View Resources

  9. Ways in which the broader health reform process can be leveraged to improve research and translation opportunities in preventative health and in the primary, aged and acute care sectors, including through expanded clinical networks, as well as ways in which research can contribute to the design and optimal implementation of these health reforms.

    View Resources

  10. Ways in which health and medical research interacts, and should interact, with other Government health policies and programs; including health technology assessments and the pharmaceutical and medical services assessment processes.

    View Resources

  11. Ways in which the Commonwealth’s e-health reforms can be leveraged to improve research and translation opportunities, including the availability, linkage and quality of data.

    View Resources

  12. The degree of alignment between Australia’s health and medical research activities and the determinants of good health, the nation’s burden of disease profile and national health priorities, in particular “closing the gap” between indigenous and non-indigenous Australians.

    View Resources

  13. Opportunities for Australia’s health and medical research activities to assist in combating some of the major barriers to improved health globally, especially in the developing world.

    View Resources

 

 

 

Page reviewed: 29 June, 2012